Describe the role of the NO-sGC-cGMP pathway in the pathophysiology of HFrEF Recognize patients with HFrEF after a WHF event and assess the risk of recurrent cardiovascular events Evaluate the safety/efficacy data and mechanisms of action of guideline-directed pharmacological therapies for the treatment of HFrEF Implement guideline-directed pharmacotherapeutic strategies to decrease overall morbidity, mortality, and hospitalization rates in patients with HFrEF and WHF
- Provider:HMP Education
- Activity Link: https://www.hmpeducation.com/program/24-pupc-102-5
- Start Date: 2024-08-23 05:00:00
- End Date: 2024-08-23 05:00:00
- Credit Details: AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Dietetic CPEUs: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
- Commercial Support: Source: Merck (Any division) - Amount: 0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: General Surgery
Subscribe
Login
0 Comments
Oldest